Cilostazol and Daliresp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cilostazol (cilostazol) and Daliresp (roflumilast). Common drug interactions include rectal haemorrhage among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Cilostazol and Daliresp. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cilostazol?

Cilostazol has active ingredients of cilostazol. It is often used in arteriosclerosis of the extremities. eHealthMe is studying from 7,877 Cilostazol users. Check the latest studies of Cilostazol.

What is Daliresp?

Daliresp has active ingredients of roflumilast. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 4,722 Daliresp users. Check the latest studies of Daliresp.

On Jul, 09, 2026

11 people who take Cilostazol and Daliresp together, and have interactions are studied.

Cilostazol and Daliresp drug interactions.

What are the common drug interactions of Cilostazol and Daliresp, by gender? *:

female:

Rectal haemorrhage (bleeding from anus)
Back pain
Drug ineffective
Headache (pain in head)
Hearing impaired
Death
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Fall
Hip fracture
Parkinson's disease

male:

Decreased appetite
Weight decreased
Pyrexia (fever)
Back pain
Chills (felling of cold)
Hospitalisation
Hyperhidrosis (abnormally increased sweating)
Insomnia (sleeplessness)
Lower extremity mass (mass in lower legs)
Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Cilostazol and Daliresp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Rectal haemorrhage (bleeding from anus)
Decreased appetite
Back pain
Chills (felling of cold)
Hospitalisation
Hyperhidrosis (abnormally increased sweating)
Insomnia (sleeplessness)
Lower extremity mass (mass in lower legs)
Nausea (feeling of having an urge to vomit)
Pain in extremity

What are the existing conditions these people have? *

Pain: 3 people, 27.27%
Immunodeficiency Common Variable: 2 people, 18.18%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 18.18%
Blood Disorder: 2 people, 18.18%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 9.09%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 1 person, 9.09%
Neuropathy Peripheral (surface nerve damage): 1 person, 9.09%
Hypoaesthesia Eye (reduced sense of touch or sensation on eyes): 1 person, 9.09%
High Blood Cholesterol: 1 person, 9.09%
Constipation: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cilostazol and Daliresp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously